Van Eck Associates Corp Gsk PLC Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$42.05 - $47.77 $16.4 Million - $18.7 Million	-391,090 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$40.23 - $47.74 $710,703 - $843,374	17,666 Added 4.73%	391,090 $17 Million
Q4 2021 Jan 26, 2022	BUY	$38.88 - $45.31 $166,872 - $194,470	4,292 Added 1.16%	373,424 $16.5 Million
Q3 2021 Nov 03, 2021	BUY	$38.79 - $43.16 $3.89 Million - $4.33 Million	100,258 Added 37.29%	369,132 $14.1 Million
Q2 2021 Aug 10, 2021	SELL	$36.52 - $41.46 $877,429 - $996,117	-24,026 Reduced 8.2%	268,874 $10.7 Million
Q1 2021 May 13, 2021	SELL	$34.27 - $40.01 $227,587 - $265,706	-6,641 Reduced 2.22%	292,900 $10.5 Million
Q4 2020 Feb 09, 2021	BUY	$34.07 - $39.94 $1.09 Million - $1.28 Million	32,072 Added 11.99%	299,541 $11 Million
Q3 2020 Nov 12, 2020	SELL	$38.11 - $42.99 $407,395 - $459,563	-10,690 Reduced 3.84%	267,469 $10.1 Million
Q2 2020 Aug 10, 2020	BUY	$37.87 - $43.58 $1.7 Million - $1.96 Million	44,871 Added 19.23%	278,159 $11.3 Million
Q1 2020 May 12, 2020	BUY	$32.47 - $48.83 $643,587 - $967,859	19,821 Added 9.29%	233,288 $8.84 Million
Q4 2019 Feb 13, 2020	BUY	$42.0 - $48.25 $1.55 Million - $1.78 Million	36,818 Added 20.84%	213,467 $10 Million
Q3 2019 Nov 08, 2019	SELL	$40.46 - $43.52 $1.48 Million - $1.59 Million	-36,540 Reduced 17.14%	176,649 $7.54 Million
Q2 2019 Aug 07, 2019	SELL	$39.4 - $42.7 $728,624 - $789,651	-18,493 Reduced 7.98%	213,189 $8.53 Million
Q1 2019 May 13, 2019	SELL	$38.57 - $42.69 $3.82 Million - $4.23 Million	-99,126 Reduced 29.96%	231,682 $9.68 Million
Q4 2018 Feb 12, 2019	SELL	$37.8 - $42.69 $443,771 - $501,180	-11,740 Reduced 3.43%	330,808 $12.6 Million
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $35,019 - $37,609	-881 Reduced 0.26%	342,548 $13.8 Million
Q2 2018 Aug 13, 2018	BUY	$39.61 - $42.76 $293,985 - $317,364	7,422 Added 2.21%	343,429 $13.8 Million
Q1 2018 May 11, 2018	SELL	$36.18 - $40.15 $1.91 Million - $2.12 Million	-52,874 Reduced 13.6%	336,007 $13.1 Million
Q4 2017 Feb 12, 2018	BUY	$35.34 - $41.9 $1.61 Million - $1.9 Million	45,420 Added 13.22%	388,881 $13.8 Million
Q3 2017 Nov 09, 2017	BUY	$39.44 - $41.55 $1.25 Million - $1.31 Million	31,611 Added 10.14%	343,461 $13.9 Million
Q2 2017 Aug 11, 2017	BUY	N/A	311,850	311,850 $13.4 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account